Home › Funds › Harvest Portfolios Group Inc. › VRTX
Harvest Portfolios Group Inc. position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
Harvest Portfolios Group Inc. reported holding 150,045 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$78.4M, representing 0.99% of its reported portfolio and ranking #29 among its reported holdings. Harvest Portfolios Group Inc. has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Harvest Portfolios Group Inc.'s VRTX position evolved
Harvest Portfolios Group Inc. first disclosed a stake in VRTX in Q2 2026 at 148,195 shares (US$73.6M). The position peaked in Q3 2026 at 150,045 shares, worth US$78.4M. Across 2 filings, Harvest Portfolios Group Inc. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 150,045 shares valued at US$78.4M — an increase of 1,850 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 148.19K | $73.61M | New |
| Q3 2026 | 150.04K | $78.45M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VRTX and 13F data
VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 32 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$13.58B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRTX
- Capital World Investors 25.97M sh · $13.58B · Q3 2026
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Capital Research Global Investors 17.81M sh · $9.31B · Q3 2026
- Invesco Ltd 8.28M sh · $4.33B · Q3 2026
- Capital International Investors 5.06M sh · $2.65B · Q3 2026
- Franklin Resources 4.46M sh · $2.45B · Q3 2026
- LOOMIS SAYLES & CO L P 3.62M sh · $1.89B · Q3 2026
- JENNISON ASSOCIATES LLC 3.00M sh · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M sh · $1.35B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.56M sh · $1.34B · Q3 2026
- Janus Henderson Group 2.13M sh · $951.79M · Q1 2026
More on Harvest Portfolios Group Inc.
FAQ
How long has Harvest Portfolios Group Inc. held VRTX?
Harvest Portfolios Group Inc. has disclosed VRTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Harvest Portfolios Group Inc.'s current position in VRTX?
As of Q3 2026, Harvest Portfolios Group Inc. holds 150.04K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $78.45M, representing 0.99% of its reported portfolio and ranking #29.
Has Harvest Portfolios Group Inc. been buying or selling VRTX?
In the latest 13F filing (Q3 2026), Harvest Portfolios Group Inc. increased its position in VRTX. The position peaked in Q3 2026 at 150.04K shares.
Which other funds hold VRTX?
Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.